Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Plos One|February 4, 2014
Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cellsPrathap Kumar S Mahalingaiah, Kamaleshwar P Singh
Molecular Pharmacology|November 1, 2015
Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic MechanismLogeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Kamaleshwar P Singh
Breast Cancer Research and Treatment|July 26, 2015
Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cellsPrathap Kumar S Mahalingaiah, Logeswari Ponnusamy, Kamaleshwar P Singh
Advances in Clinical Chemistry|January 19, 2020
Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistanceLogeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Kamaleshwar P Singh
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 30, 2017
Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cellsLogeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Kamaleshwar P Singh
Oncotarget|September 23, 2016
Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cellsPrathap Kumar S Mahalingaiah, Logeswari Ponnusamy, Kamaleshwar P Singh
Journal of Cellular Physiology|December 30, 2014
Chronic oxidative stress leads to malignant transformation along with acquisition of stem cell characteristics, and epithelial to mesenchymal transition in human renal epithelial cellsPrathap Kumar S Mahalingaiah, Logeswari Ponnusamy, Kamaleshwar P Singh
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 18, 2018
Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cellsLogeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Yu-Wei Chang, et al.
Breast Cancer Research and Treatment|February 10, 2015
Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cellsTulika Tyagi, Justin N Treas, Prathap Kumar S Mahalingaiah, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancerLogeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Yu-Wei Chang, et al.
Pageof 2